Ready-made, standardized plasmid DNA constructs that encode tumor antigens. Each indication uses a distinct antigen-encoding construct on the same circular plasmid backbone, enabling rapid development and scalable manufacturing.
Individualized mRNA vaccines designed around the specific antigen profile of each patient, directing a precise immune response against disease — in cancer and in autoimmune conditions.
From a ready-made DNA construct to an antigen-specific immune attack on cancer cells, in five steps.
A circular, double-stranded plasmid carries a tumor antigen gene and promoter on a plasmid backbone.
Ready-made DNA construct
The construct is formulated as an off-the-shelf, standardized vaccine.
Off-the-shelf
The vaccine is delivered by intramuscular injection.
Intramuscular injection
Plasmid DNA enters the nucleus, is transcribed to mRNA and translated into antigen protein.
DNA → mRNA → Antigen
Dendritic cells present antigen fragments, activating T cells that target and destroy cancer cells.
Cancer cell destructionModular platform — different antigen constructs for each indication
Distinct antigen-encoding construct
Distinct antigen-encoding construct
Distinct antigen-encoding construct
Conceptual mechanism illustration; investigational platform, not an approved cancer treatment.